Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00205062
NCT00205062TerminatedPhase 4

Pilot Study of the Role of PET-CT for Diagnosis and Assessment of Therapeutic Efficacy in Inflammatory Bowel Disease

University of Wisconsin, Madison2 sites in 1 countryStarted: October 2004Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 4
Status
Terminated
Locations
2
Primary Endpoint
Does this technique provide an accurate assessment of disease inflammation compared to standard clinical markers?
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The main hypothesis is that PET-CT will be a valuable diagnostic tool in diagnosing and evaluating treatment for IBD.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patient with either Crohn's disease or ulcerative colitis whose disease is flaring

Exclusion Criteria

  • •Indeterminate diagnosis, pregnant, breastfeeding, or other contraindication to PET-CT

Outcomes

Primary Outcomes

Does this technique provide an accurate assessment of disease inflammation compared to standard clinical markers?

Secondary Outcomes

  • Does this technique provide additional information for practitioners on extent of disease?

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Completed
Not Applicable
PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation TherapyCarcinoma of Unknown PrimaryHead and Neck Cancer
NCT00388024Wake Forest University Health Sciences19
Completed
Not Applicable
A Pilot Clinical Study of PET Scanning in Evaluation of Vaccine ReactogenicityPositron-Emission TomographyImmunization Reaction
NCT04515368Imperial College London54
Completed
Not Applicable
A Study to Assess Thymic Function Using PET/CT and MRICD34 Selected Peripheral Blood Stem Cell Graft
NCT02909075Memorial Sloan Kettering Cancer Center3
Unknown
Not Applicable
Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early StageProstate Cancer
NCT04116086Sheba Medical Center50
Recruiting
Early Phase 1
Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular CarcinomaMalignant Neoplasm of Liver
NCT06383520Wuhan Union Hospital, China100